BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1835 related articles for article (PubMed ID: 18059259)

  • 21. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
    Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies toward CNS-regeneration using induced pluripotent stem cells.
    Okano H
    Genome Inform; 2009 Oct; 23(1):217-20. PubMed ID: 20180278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.
    Chang CW; Lai YS; Pawlik KM; Liu K; Sun CW; Li C; Schoeb TR; Townes TM
    Stem Cells; 2009 May; 27(5):1042-9. PubMed ID: 19415770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
    Hotta A; Ellis J
    J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons.
    Talluri TR; Kumar D; Glage S; Garrels W; Ivics Z; Debowski K; Behr R; Kues WA
    Biochem Biophys Res Commun; 2014 Jul; 450(1):581-7. PubMed ID: 24928388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
    Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
    Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
    Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
    Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of human induced pluripotent stem cells.
    Ohnuki M; Takahashi K; Yamanaka S
    Curr Protoc Stem Cell Biol; 2009 Jun; Chapter 4():Unit 4A.2. PubMed ID: 19536759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oct4-induced pluripotency in adult neural stem cells.
    Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR
    Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and activation of the reprogramming transcription factors.
    Guo J; Li ZC; Feng YH
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1081-6. PubMed ID: 19900408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era.
    Yuasa S; Fukuda K
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):803-10. PubMed ID: 18570618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The magic continues for the iPS strategy.
    Pei D
    Cell Res; 2008 Feb; 18(2):221-3. PubMed ID: 18246087
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts.
    Jin J; Kwon YW; Paek JS; Cho HJ; Yu J; Lee JY; Chu IS; Park IH; Park YB; Kim HS; Kim Y
    J Proteome Res; 2011 Mar; 10(3):977-89. PubMed ID: 21175196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion of pluripotent human embryonic stem cells on human feeders.
    Choo AB; Padmanabhan J; Chin AC; Oh SK
    Biotechnol Bioeng; 2004 Nov; 88(3):321-31. PubMed ID: 15486939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
    Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
    Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem (iPS) cell research overview.
    Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 92.